Lensar (LNSR) Gains from Sales and Divestitures (2019 - 2026)
Lensar (LNSR) reported Gains from Sales and Divestitures of $122000.0 for Q1 2026, down 29.07% year-over-year from $172000.0 in Q1 2025, and down 58.36% quarter-over-quarter from $293000.0 in Q4 2025.
Lensar (LNSR) Gains from Sales and Divestitures (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 7 years of Gains from Sales and Divestitures data on file, last reported at $122000.0 in Q1 2026.
- Gains from Sales and Divestitures for Q1 2026 came in at $122000.0, down 29.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $122000.0 (down 29.07% YoY), and the FY2025 annual result was $293000.0, up 22.59% from the prior year.
- Gains from Sales and Divestitures slipped to $122000.0 in Q1 2026 per LNSR's latest filing, from $293000.0 in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $704000.0 in Q4 2022 and troughed at $84000.0 in Q1 2024.
- A 5-year average of $338941.2 and a median of $293000.0 in 2025 frame the typical range for Gains from Sales and Divestitures.
- The sharpest annual moves came in 2022 and 2024: Gains from Sales and Divestitures jumped 100109.64% in 2022, then slumped 64.56% in 2024.
- A 5-year view of Gains from Sales and Divestitures shows it stood at $704000.0 in 2022, then fell by 12.5% to $616000.0 in 2023, then sank by 61.2% to $239000.0 in 2024, then rose by 22.59% to $293000.0 in 2025, then slumped by 58.36% to $122000.0 in 2026.
- Business Quant data shows LNSR's Gains from Sales and Divestitures at $122000.0 in Q1 2026, $293000.0 in Q4 2025, and $293000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Lensar | 70.05 Mn | 70.34 Mn | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 122,000.00 |
| Mar 31, 2026 | 122,000.00 |
| Dec 31, 2025 | 293,000.00 |
| Dec 31, 2025 | 293,000.00 |
| Sep 30, 2025 | 293,000.00 |
| Sep 30, 2025 | 293,000.00 |
| Jun 30, 2025 | 292,000.00 |
| Jun 30, 2025 | 292,000.00 |
| Mar 31, 2025 | 172,000.00 |
| Mar 31, 2025 | 172,000.00 |
| Dec 31, 2024 | 239,000.00 |
| Dec 31, 2024 | 239,000.00 |
| Sep 30, 2024 | 240,000.00 |
| Sep 30, 2024 | 240,000.00 |
| Jun 30, 2024 | 149,000.00 |
| Jun 30, 2024 | 149,000.00 |
| Mar 31, 2024 | 84,000.00 |
| Mar 31, 2024 | 84,000.00 |
| Dec 31, 2023 | 616,000.00 |
| Dec 31, 2023 | 616,000.00 |